Lab
LSP Southeast, LLC
LSP Southeast, LLC was paid $456K by Medicaid between Feb 2024 and Dec 2024, across 20 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 39% of everything it billed.
33Billing provider infoLSP SOUTHEAST, LLC
BAY ST LOUIS, MS 39520
BAY ST LOUIS, MS 39520
33aNPI1104517424assigned 05/17/2023
33bProvider typeClinical Medical Laboratory
28Total paid$456K
24GClaims11,537
24DCodes billed20
24AFirst – last monthFeb 2024 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Mississippi
Rank by total paid#14 of 35
Median peer was paid$136K
This provider vs. median3.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 11,537 | $456K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 39% | 1,311 | 1,081 | $177K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 21% | 357 | 287 | $94K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 12% | 831 | 674 | $53K |
| 87641 | 4.4% | 1,314 | 1,036 | $20K | |
| 87581 | 3.9% | 1,195 | 966 | $18K | |
| 87498 | 3.9% | 1,172 | 944 | $18K | |
| 87541 | 3.9% | 1,172 | 944 | $18K | |
| 87486 | 3.9% | 1,172 | 944 | $18K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.7% | 1,025 | 813 | $12K |
| 87561 | 2.0% | 357 | 287 | $9K | |
| 87481 | 1.8% | 152 | 128 | $8K | |
| 87640 | 1.3% | 1,109 | 886 | $6K |
8 more codes
| 87653 | <1% | 155 | $3K | |
| 87500 | <1% | 127 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $323.26 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 16 | $221.06 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 16 | $221.06 |
| 87511 | <1% | 13 | $189.48 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 14 | $189.48 |
| 87529 | <1% | 16 | $63.16 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZELKOVICH, ALYSSA (MANAGING PARTNER)